Report shows 241 blood cancer drugs in the pipeline

04/29/2013 | Drug Store News

According to the Pharmaceutical Research and Manufacturers of America, as many as 241 blood cancer medications are undergoing clinical development or FDA assessment, 98 of which are dedicated to lymphoma treatment, while 97 are for leukemia, 52 target multiple myeloma and 24 address bone marrow, blood and lymph node malignancies.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD